Table 3 Associations of patient and tumor characteristics with the disease free survival (DFS) and overall survival (OS) rates.
From: Is the thymidine labeling index a good prognostic marker in breast cancer?
Variable | 5-year DFS rate (%) | P-value | 5-year OS rate | P-value |
|---|---|---|---|---|
Age | 0.745 | 0.319 | ||
≤50 years | 74.3 | 76.1 | ||
>50 years | 74.1 | 61.9 | ||
Tumor | 0.002 | 0.001 | ||
pT1 | 83.4 | 81.9 | ||
Other (pT2+ pT3+pT4) | 69.0 | 61.7 | ||
Node | 0.0001 | 0.004 | ||
pN0 | 85.1 | 79.5 | ||
pN1+pN2+pN3 | 66.0 | 61.4 | ||
Nuclear Grade | 0.007 | 0.032 | ||
1+2 | 76.4 | 70.5 | ||
3 | 67.7 | 66.7 | ||
Histologic Grade | 0.080 | 0.093 | ||
1+2 | 78.9 | 75.9 | ||
3 | 67.2 | 61.2 | ||
Estrogen receptor status | 0.030 | 0.016 | ||
ER-positive | 78.1 | 74.3 | ||
ER-negative | 64.6 | 59.1 | ||
Progesterone receptor status | 0.331 | 0.567 | ||
PR-positive | 79.0 | 71.1 | ||
PR-negative | 71.4 | 68.2 | ||
Lymphovascular invasion | 0.088 | 0.058 | ||
Yes | 69.2 | 63.5 | ||
No | 74.7 | 70.6 | ||
TLI status | 0.353 | 0.084 | ||
Low TLI | 76.9 | 75.4 | ||
High TLI | 72.4 | 64.8 |